Candice Rabusa

708 total citations
17 papers, 507 citations indexed

About

Candice Rabusa is a scholar working on Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Candice Rabusa has authored 17 papers receiving a total of 507 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pathology and Forensic Medicine, 11 papers in Pulmonary and Respiratory Medicine and 5 papers in Molecular Biology. Recurrent topics in Candice Rabusa's work include Systemic Sclerosis and Related Diseases (16 papers), Pulmonary Hypertension Research and Treatments (7 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers). Candice Rabusa is often cited by papers focused on Systemic Sclerosis and Related Diseases (16 papers), Pulmonary Hypertension Research and Treatments (7 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers). Candice Rabusa collaborates with scholars based in Australia, Canada and United Kingdom. Candice Rabusa's co-authors include Wendy Stevens, Susanna Proudman, Mandana Nikpour, Kathleen Morrisroe, Molla Huq, Joanne Sahhar, Yanjie Hao, Marie Hudson, Murray Baron and Jane Zochling and has published in prestigious journals such as Annals of the Rheumatic Diseases, Medicine and Arthritis Research & Therapy.

In The Last Decade

Candice Rabusa

15 papers receiving 506 citations

Peers

Candice Rabusa
Bernard Coleiro Malta
Sébastien Sanges France
Hélène Chifflot France
Ariel Masetto Canada
María Jesús Castillo‐Palma Spain
Traci Housten United States
Jinzhi Lai China
Elżbieta Kamińska Canada
A. Hij France
Diana Castillo‐Martínez Mexico
Bernard Coleiro Malta
Candice Rabusa
Citations per year, relative to Candice Rabusa Candice Rabusa (= 1×) peers Bernard Coleiro

Countries citing papers authored by Candice Rabusa

Since Specialization
Citations

This map shows the geographic impact of Candice Rabusa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Candice Rabusa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Candice Rabusa more than expected).

Fields of papers citing papers by Candice Rabusa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Candice Rabusa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Candice Rabusa. The network helps show where Candice Rabusa may publish in the future.

Co-authorship network of co-authors of Candice Rabusa

This figure shows the co-authorship network connecting the top 25 collaborators of Candice Rabusa. A scholar is included among the top collaborators of Candice Rabusa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Candice Rabusa. Candice Rabusa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Ferdowsi, Nava, Molla Huq, Wendy Stevens, et al.. (2019). Development and validation of the Scleroderma Clinical Trials Consortium Damage Index (SCTC-DI): a novel instrument to quantify organ damage in systemic sclerosis. Annals of the Rheumatic Diseases. 78(6). 807–816. 37 indexed citations
2.
Ross, Laura, Wendy Stevens, Candice Rabusa, et al.. (2019). The role of inflammatory markers in assessment of disease activity in systemic sclerosis.. PubMed. 36 Suppl 113(4). 126–134. 27 indexed citations
3.
Thakkar, Vivek, Wendy Stevens, David L. Prior, et al.. (2017). The role of asymmetric dimethylarginine alone and in combination with N-terminal pro-B-type natriuretic peptide as a screening biomarker for systemic sclerosis-related pulmonary arterial hypertension: a case control study.. PubMed. 34 Suppl 100(5). 129–136. 16 indexed citations
4.
Owen, Claire, Gene‐Siew Ngian, O. Moore, et al.. (2017). Mycophenolate mofetil is an effective and safe option for the management of systemic sclerosis-associated interstitial lung disease: results from the Australian Scleroderma Cohort Study.. PubMed. 34 Suppl 100(5). 170–176. 28 indexed citations
5.
Morrisroe, Kathleen, Wendy Stevens, Joanne Sahhar, et al.. (2017). Epidemiology and disease characteristics of systemic sclerosis-related pulmonary arterial hypertension: results from a real-life screening programme. Arthritis Research & Therapy. 19(1). 42–42. 63 indexed citations
6.
Morrisroe, Kathleen, Wendy Stevens, Joanne Sahhar, et al.. (2017). Quantifying the direct public health care cost of systemic sclerosis. Medicine. 96(48). e8503–e8503. 16 indexed citations
7.
Morrisroe, Kathleen, Molla Huq, Wendy Stevens, & Candice Rabusa. (2017). Determinants of unemployment amongst Australian systemic sclerosis patients: results from a multicentre cohort study.. PubMed. 34(5). 79–84. 27 indexed citations
8.
Hao, Yanjie, Marie Hudson, Murray Baron, et al.. (2016). Early Mortality in a Multinational Systemic Sclerosis Inception Cohort. Arthritis & Rheumatology. 69(5). 1067–1077. 138 indexed citations
9.
Brown, Zoe, Wendy Stevens, Joanne Sahhar, et al.. (2016). The association of low complement with disease activity in systemic sclerosis: a prospective cohort study. Arthritis Research & Therapy. 18(1). 246–246. 9 indexed citations
10.
Morrisroe, Kathleen, Molla Huq, Wendy Stevens, et al.. (2016). Risk factors for development of pulmonary arterial hypertension in Australian systemic sclerosis patients: results from a large multicenter cohort study. BMC Pulmonary Medicine. 16(1). 134–134. 33 indexed citations
11.
Morrisroe, Kathleen, et al.. (2016). AB0607 Determinants of Unemployment amongst Australian Systemic Sclerosis Patients. Annals of the Rheumatic Diseases. 75. 1112–1112. 1 indexed citations
12.
Morrisroe, Kathleen, et al.. (2016). SAT0235 Survival in Systemic Sclerosis Related Pulmonary Arterial Hypertension in The Modern Treatment Era: Results from A Multicentre Australian Cohort Study. Annals of the Rheumatic Diseases. 75. 753–754. 1 indexed citations
13.
Hao, Yanjie, Vivek Thakkar, Wendy Stevens, et al.. (2015). A comparison of the predictive accuracy of three screening models for pulmonary arterial hypertension in systemic sclerosis. Arthritis Research & Therapy. 17(1). 7–7. 88 indexed citations
14.
Thakkar, Vivek, Kathleen Morrisroe, D. B. Prior, et al.. (2015). Cost savings with a new screening algorithm for pulmonary arterial hypertension in systemic sclerosis. Internal Medicine Journal. 45(11). 1134–1140. 17 indexed citations
15.
16.
Hao, Yue, Wendy Stevens, Kathleen Morrisroe, et al.. (2014). A comparison of the predictive accuracy of three screening models (DETECT v.ESC/ERS v. ASIG) for pulmonary arterial hypertension in systemic sclerosis. Internal Medicine Journal. 44(11). 23–23. 1 indexed citations
17.
Tay, T.E., Maayan Baron, Marie Hudson, et al.. (2014). Early accrual of organ damage in scleroderma: rationale for derivation and validation of a disease damage index in systemic sclerosis. Adelaide Research & Scholarship (AR&S) (University of Adelaide).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bernard Coleiro Breakdown of academic impact, for papers by Sébastien Sanges Breakdown of academic impact, for papers by Hélène Chifflot Breakdown of academic impact, for papers by Ariel Masetto Breakdown of academic impact, for papers by María Jesús Castillo‐Palma Breakdown of academic impact, for papers by Traci Housten Breakdown of academic impact, for papers by Jinzhi Lai Breakdown of academic impact, for papers by Elżbieta Kamińska Breakdown of academic impact, for papers by A. Hij Breakdown of academic impact, for papers by Diana Castillo‐Martínez
Rankless by CCL
2026